Glaxosmithkline PLC ORD 25P | 1,764.0 / +1.87% |
News
- GSK's turnover at £9.78B in Q1, up 32% YoY
04/27/2022 / 08:10 - TeleTrader - EMA begins reviewing Sanofi-GSK COVID-19 vaccine
03/30/2022 / 17:37 - TeleTrader - US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA.2 Subvariant
03/25/2022 / 21:04 - GlobeNewswire - Radius Health Announces Leadership Appointments
03/16/2022 / 13:30 - GlobeNewswire - Surface Oncology to Participate in Novel Immuno-Oncology Panel at Cowen’s 42nd Annual Health Care Conference
02/28/2022 / 22:30 - GlobeNewswire - Cullinan Oncology Expands Leadership Team and Board of Directors with Appointments of Jeffrey Jones, M.D., MPH, MBA to Chief Medical Officer and Anne-Marie Martin Ph.D. to Board of Directors
02/28/2022 / 14:00 - GlobeNewswire - Alector Reports Fourth Quarter and Full Year 2021 Financial Results
02/24/2022 / 22:05 - GlobeNewswire - Sanofi, GSK to ask for COVID-19 vaccine authorization
02/23/2022 / 12:30 - TeleTrader - Surface Oncology to Participate in Citi's 2022 Virtual Immuno-Oncology Summit
02/10/2022 / 13:00 - GlobeNewswire - Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2
02/10/2022 / 07:24 - GlobeNewswire - Europe opens higher with earnings, data in focus
02/09/2022 / 09:03 - TeleTrader - GSK: Q4 turnover increases 9% to £9.5B
02/09/2022 / 08:15 - TeleTrader - Europe up in premarket ahead of Germany's trade data
02/09/2022 / 08:01 - TeleTrader - Unilever says GSK is 'strong fit' after rejected bid
01/17/2022 / 11:49 - TeleTrader - Europe opens higher amid the Forum, COVID data
01/17/2022 / 09:05 - TeleTrader